The UAE Cabinet has authorized the board of administrators of the Emirates Drug Establishment, which shall be chaired by Dr. Thani Al Zeyoudi, Minister of State for Foreign Trade.
Dr. Fatima Al Kaabi has been assigned to hold out the duties of director common of the newly-formed entity.
The board contains Dr. Maha Taysir Barakat, Assistant Minister for Medical Affairs & Life Sciences at Ministry of Foreign Affairs because the Vice Chairman; Dr. Essa Abdulfattah Kazim, Governor of the Dubai International Financial Centre; Badr Al Olama, Acting Director General of the Abu Dhabi Investment Office; Dr. Amer Ahmad Sharif, CEO of Dubai Academic Health Corporation; Dr. Farhan Malik, Group CEO of PureHealth; Professor Christopher Evans, scientific researcher and businessman; along with a youth consultant nominated by the General Secretariat of the Cabinet.
The Emirates Drug Establishment goals to strengthen the nation’s place as a worldwide hub for pharmaceutical and medical industries, promote analysis and growth on this sector and supply a nurturing setting for pharmaceutical investments.
The entity may also contribute to enhancing the manufacturing, growth and export of high-quality medical and pharmaceutical merchandise, in addition to making certain the provision, effectiveness and security of those merchandise.
UAE Cabinet approves the formation of the Board of Directors of Emirates Drug Establishment
Dr. Fatima Alkaabi to hold out the duties of director common of the institution pic.twitter.com/U7JrnXeXN3— UAEGOV (@UAEmediaoffice) December 7, 2023
